Last week brought a flurry of news coverage around a proposed $1 billion fund to support a biotech park near Rochester. In the end, though, we were left not knowing much more than we did at the start of the week.
San Francisco biotech investor Steven Burrill
told the Star Tribune that he was close to completing the billion-dollar deal, which would help fund the Elk Run BioBusiness Park in Pine Island, Minn.
The next day, Burrill softened/hedged/clarified his words in
a press release, saying that no deal is guaranteed.
MedCityNews recaps the statements and concludes that maybe Burrill should have stuck with "We're making progress. Hopefully, we'll have a deal soon."